I review 4 mREITs that I believe offer a buying opportunity for income-oriented investors with a long-term horizon. Find out why my favorite is Ready Capital.Read full newsRead More
Acrivon has a platform that tests trial patients for sensitivity to a tested drug before enrolling them. See why I'm neutral on ACRV stock.Read full newsRead More
The Fed hiked in the middle of a banking crisis and the S&P500 closed the week higher. What this could mean for the week ahead.Read full newsRead More
Helen of Troy is dealing with multiple issues as it embarks on a restructuring program. Click here to read my analysis of HELE stock.Read full newsRead More
In light of the interest-rate-risk-driven failure of SVB on March 10, we've added a chart showing how interest rate mismatching increases default risk.Read full newsRead More
Two new Breakout Stocks for Week 13 with better than 10% short-term upside and a Dow 30 Pick. Read more to see our weekly update.Read full newsRead More
Genco Shipping pays a variable quarterly dividend - its forward yield is 12.85%, and its trailing yield is over 16%. See why we rate GNK stock a long-term buy.Read full newsRead More
2022 was record year for Kazatomprom, with revenues up around 45% on back of rising uranium prices, profits doubling. Check out my thoughts on Kazatomprom stock.Read full newsRead More
Fifth Third Bancorp is a solid banking franchise that got unfairly punished during the March financial crisis. Click here to see our take on FITB stock.Read full newsRead More
Currently, Global Medical REIT offers close to a 10% dividend yield that is still underpinned with robust fundamentals. Click here to see our take on GMRE.Read full newsRead More
This monthly series ranks a selection of dividend growth stocks in Dividend Radar and presents the ten top-ranked stocks for consideration.Read full newsRead More
US equity markets posted gains while benchmark interest rates dipped to the lowest levels of the year. Check out real estate weekly outlook and economic data.Read full newsRead More
Air Products & Chemicals is more than a singular missed earnings report that the market is punishing it for. Click here to see our take on APD stock.Read full newsRead More
ARKK has been destroyed since 2021. However, it owns exactly the right kinds of names for what I believe is a massive bull run in 2023. See why I'm bullish on the fund.Read full newsRead More
Fed's Bank Term Funding Program partially resolved liquidity issues. It would be a grave error to consider liquidity injection as quantitative easing.Read full newsRead More
Atlas Lithium has things going for it, certainly. That Mitsui agreement is interesting, for example. Read why I think ATLX stock is overvalued currently.Read full newsRead More
I feel like the midstream energy sub-sector is likely to include some quality businesses at favorable valuations. Check out my recommended stocks.Read full newsRead More
PacWest Bancorp has not been immune to the carnage seen in the banking industry, and understandably so. See why I'm bullish on PACW stock.Read full newsRead More
Advanced Micro Devices has finally rallied back to $100, but the market should really be focusing on the next $100. Click here to see our take on AMD stock.Read full newsRead More
Bank of America ended Q4 with $868B of global liquidity sources. See why I expect BAC stock to be a winner amidst this manic-depressive market environment.Read full newsRead More